Onconova adopts single-cell DNA analysis platform
Onconova to use Mission Bio’s Tapestri targeted single-cell DNA analysis platform to advance its cancer therapy, rigosertib, into Phase III clinical trials.
Archives for August 13, 2019
VitaLink acquires Comprehensive Clinical Trials
The clinical research site business, VitaLink Research, has acquired FL-based Comprehensive Clinical Trials, which conducts women’s health-focused Ph II-IV clinical trials.
Seres distances itself from quality problems at other microbiome groups
Seres Therapeutics draws distinction between its quality practices and those of the fecal microbiota for transplantation (FMT) operations that triggered FDA alert.
Boehringer Ingelheim, MD Anderson launch virtual research and development center
Boehringer Ingelheim and the University of Texas MD Anderson Cancer Center entered a multi-year partnership to conduct collaborative translational research for lung and GI cancers.
Urovant ramps up spending on Codexis ingredient ahead of commercial production
Urovant Sciences’ preparations to file for US approval of vibegron add to Codexis’ sales in the second quarter.
Saama acquires Comprehend, combining strengths and elevating ability to innovate
Saama Technologies today announced that it has signed a definitive agreement to acquire Comprehend Systems, creating an ‘enhanced suite of complementary capabilities’ to ‘facilitate more rapid drug development,’ says company executives.
Cancer Research UK backs Hummingbird’s cancer treatment development
Cancer Research UK to support the clinical development of Hummingbird’s investigative cancer treatment which has the potential to fight drug resistant tumours.